The Claim
In sedentary adults aged 65–85 years, once-weekly sirolimus (rapamycin) 6 mg administered alongside a 13-week home-based resistance and endurance exercise program may modestly attenuate improvements in lower-body functional performance, as measured by the 30-second chair-stand test, compared to placebo, with sensitivity analyses showing statistically significant differences favoring placebo despite a non-significant primary analysis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older adults who don't move much, taking a weekly rapamycin pill might slightly weaken the benefits of a 13-week home exercise program on leg strength and mobility, according to some detailed number crunching—even though the main results weren't clear-cut.
See the scientific wording
In sedentary adults aged 65–85 years, once-weekly sirolimus (rapamycin) 6 mg combined with a 13-week home-based resistance and endurance exercise program may modestly attenuate improvements in lower-body functional performance, as measured by the 30-second chair-stand test, compared to placebo, based on sensitivity analyses showing statistically significant differences in favor of placebo despite a non-significant primary analysis.
What the research says
1 studyThe study found that older adults taking sirolimus once a week didn't improve as much on a chair-stand test as those taking a placebo, especially when looking at more detailed analyses. This supports the idea that the drug might slightly reduce exercise benefits.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.